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Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, Research Triangle Park,
NC, USA
In studies of case-parent triads, information is often collected about history of the
condition in the parents, but typically parental phenotypes are ignored. Including
that information in analyses may increase power to detect genetic association for
autosomal variants. Our proposed approach uses parental phenotypes to assess
association independently of the usual case-parent-based association test, enabling
cross-generational internal replication for findings based on offspring and their parents.
Our model for parental phenotypes also resists bias due to population stratification. We
combine the information from the two generations into a single coherent model that can
exploit approximate equality of parental and offspring relative risks to improve power
and can also test that equality. We call the resulting procedure the Parent-phenotype
Informed Likelihood Ratio Test (PPI-LRT ). When some parental genotypes are missing,
one can use the expectation-maximization algorithm to fit the combined model.
We also develop a second composite test (PPI-CT ) based on a linear combination
of the parent-phenotype-based test statistic and that from the traditional log-linear,
transmission-based test. We evaluate the proposed methods through non-centrality
parameter calculations and simulation studies and compare them to the previously
proposed approaches, parenTDT and combTDT. We show that incorporation of parental
phenotype data often improves statistical power. As illustration, we apply our method to
a study of young-onset breast cancer and find that it improved precision for SNPs in
FGFR2 and that estimated relative risks based on triads are closely replicated using the
parental data.
Keywords: case-parent triad, parental phenotype, association study, SNPs, likelihood ratio test
Introduction
In the case-parents design, a design commonly used in genetic studies, investigators collect
genotype (and exposure) data from affected individuals and their biological parents. They then
carry out analyses designed to detect the distortions in transmission to affected offspring that are
seen for SNPs associated with susceptibility. Such analyses typically neglect information on parental
phenotype. That information may, however, be able to contribute additional power, especially for
diseases that are not rare in a lifetime.
Purcell et al. (2005) developed ways to use parental phenotype information based on extending
a within-sibship association model for quantitative traits (Fulker et al., 1999). A related method,
parenTDT, is implemented in PLINK (Purcell et al., 2007). It is based on case-parent triads and
exclusively captures information from parental phenotypes. The parent-phenotype information is
combined with transmission-based information in the combTDT. Both parenTDT and combTDT
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have some drawbacks, however: they cannot use data from
triads with missing genotypes and do not provide relative
risk estimates. To address those issues, we develop alternative
methods for exploiting parent-phenotype information in a case-
parents design.
Family-based studies typically collect parental phenotype
data because investigators want to ascertain first-degree family
history. An example is the Two Sister Study (http://sisterstudy.
niehs.nih.gov/English/2sis.htm), a family-based study of breast
cancer diagnosed before age 50. DNA samples from the
cases, their parents, when available, and unaffected control
sisters (when parents were missing) were genotyped using the
Illumina HumanOmniExpressExome-8v1 array. About 20% of
the mothers had themselves been diagnosed with breast cancer.
This study motivated us to develop our method and will serve to
illustrate its application.
We first consider diseases that affect only one sex, e.g., female
breast cancer or prostate cancer. Later we expand our method to
permit study of diseases that affect both males and females.
Methods
Joint Model for Phenotypes in Parents and
Offspring
Assuming a female-specific disease, let M, F, C denote the
numbers of copies of the variant allele carried by the mother,
father and daughter, respectively and let DM and DC denote
the occurrence of the disease in the mother and daughter,
respectively. The joint distribution of the parental phenotypes
and triad genotypes can be factored into two parts as follows:
Pr (DM,M, F,C|DC) = Pr (M, F,C|DC)Pr (DM|M, F,C,DC)
(1)
Here the first factor contains the classical transmission-based
information while the second factor contains information
contributed by the parental phenotypes. These two sources of
information can be modeled separately, as will be described
below. Alternatively, the joint likelihood (1) can be maximized.
The model for risk can be parameterized to impose equality of
parental and offspring relative risks or to test that equality. The
maximization can make use of the expectation-maximization
(EM) algorithm when some parental genotypes are missing,
provided that missingness is noninformative, that is, unrelated
to the unmeasured genotype, conditional on the observed data
(Dempster et al., 1977).
Model for the Transmission-based Test
The transmission-based tests are based on modeling the
distribution of triad genotypes conditional on the offspring’s
being affected. We postulate a robust log-linear risk model
(Weinberg et al., 1998) as follows:
ln
[
Pr(M, F,C|DC)
]
= µ(M,F) + γ1I(C= 1) + γ2I(C= 2)
+ ln(2)I(M= 1,F= 1,C= 1) (2)
Here the µ(M,F) represent six mating-type parameters
corresponding to the unordered parental genotypes under
assumed mating symmetry for the allele under study. Here,
mating symmetry means that in the source population
Pr
[
M = m, F = f
]
= Pr
[
M = f , F = m
]
, which implies
that µ(M,F) = µ(F,M). These mating type parameters ensure that
inferences about the γj use only information from transmissions,
thereby conferring robustness against population stratification.
Exponentiating γ1 and γ2 yields the relative risk for a child
who carries 1 or 2 copies compared to one who carries no
copies, i.e., R1 and R2. One can test for genetic effects of the
variant by testing the null hypothesis that γ1 = γ2 = 0.
The six mating type parameters confer robustness against
population stratification by effectively forcing conditioning on
the unordered parental genotypes at the studied locus. The
co-dominant risk parameterization in (2) can be modified
to accommodate a log-additive (as used in our simulations),
dominant or recessive mode of inheritance.
Modeling Risk in a Parent
We model the phenotype of the mother of an affected daughter
using a log-binomial model as follows:
ln [Pr (DM|M, F,DC)] = α(M,F)+β1I(M= 1) + β2I(M= 2) (3)
Here, the α(M,F) represent six mating-type parameters
corresponding to the unordered parental genotypes for the
allele under study. Exponentiating β1 and β2 yields the relative
risks for disease in the mothers who carry 1 or 2 copies compared
to those who carry no copies, i.e., Rm1 and Rm2. One can test for
genetic effects of the variant by testing the null hypothesis that
β1 = β2 = 0.
In model (3), risk in mothers of cases depends on paternal
genotype through the α(M,F). These parameters provide proxy
adjustment for sub-population membership; their inclusion
confers resistance to bias due to genetic population stratification.
Formal justification of robustness appears in the Supplementary
Material. As explained there, the α(M,F) allow baseline disease
risks to differ across subpopulations; but control of stratification
bias requires certain assumptions such as mating symmetry.
Note also that the only informative pairs of parents (those who
contribute to estimation of the βj) are parents who differ in
their genotypes. Thus, robustness comes at a price. Also, we
are assuming that the relative risks do not depend on epistasis
with other causative variants that are enriched in parents of
cases. That is, we assume that the conditioning on DC can be
ignored in the modeling. (This assumption would certainly hold
under the null so has no effect on validity of testing). The risk
parameterization in (3) also can be modified to accommodate
log-additive, dominant or recessive models. Model (3) can be
fitted using procedures for generalized linear models that are
readily available in statistical packages.
Maternally-mediated Genetic Effects
The mother’s genome governs the prenatal environment and
consequently can be important to the development of the fetus,
regardless of which alleles the mother transmitted. This effect of
the mother’s genome on the phenotype of her offspring (perhaps
even long after birth) is called a maternally-mediated genetic
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effect. Suppose a fetus born to a mother with one or two copies
of a risk allele has a relative risk of S1 or S2 for developing the
disease compared to a fetus born to a mother with no copies.
Model (2) above can be modified to accommodate maternally-
mediated effects by introducing two maternal genetic-effect risk
parameters, ρ1and ρ2, as in Wilcox et al. (1998):
ln
[
Pr(M, F,C|DC)
]
= µ(M,F) + γ1I(C= 1) + γ2I(C= 2)
+ ρ1I(M= 1) + ρ2I(M= 2)
+ ln(2)I(M= 1,F= 1,C= 1) (4)
Exponentiating ρ1 and ρ2 yields the relative risk parameters
S1 and S2. One caution is that, for model (4) to produce
unbiased estimates of maternal effects there must not be an
effect of the phenotype on reproduction that is differential for
males vs. females. The parent-phenotype-based model (3) is not
readily generalized to allow the study of maternally-mediated
genetic effects unless one also has genotype data for the maternal
grandmothers. In fact, when maternally-mediated genetic effects
are present, the risk parameters in model (3) for mothers
themselves are an amalgamation of effects from the alleles the
mother inherited from her parents and maternally-mediated
genetic effects arising from her mother’s genotype.
Combining Information from the Two Generations
Let us assume from here on that model (4) has been applied to the
case-parent data and provided no evidence for any maternally-
mediated effects of the variant under study. We presume no
maternal effects and turn next to the problem of devising a
two-generational approach to studying the direct effects of the
inherited variant. Using the likelihood in (1) together with
models (2) and (3), one can base estimation and testing on
information from both generations. When the data are complete
and distinct risk parameters are used for offspring and parents,
maximizing the combined likelihood confers no advantages—
statistical results for complete data would be the same as with
separate fits to models (2) and (3). When parental genotypes
are missing or when a functional relationship between offspring
and parent risk parameters is specified, however, using the
combined model is beneficial. For example, one might specify
that R1 = Rm1 and R2 = Rm2 to allow both offspring and
parent information to contribute to risk estimation and testing.
The relative risk parameters for mothers (Rm1 and Rm2) may
not be identical to their counterparts for offspring (R1 and R2,
respectively), in part because ages at onset may be systematically
different, but setting them equal for modeling and testing may
still be useful. We designate the resulting parent-phenotype-
informed likelihood ratio test as PPI-LRT.
Alternatively, in the absence of missing genotypes, one can
fit the transmission model and the parent-phenotype model
separately and then combine the independent test statistics
as a way to take advantage of the information provided by
both generations. First, fit the same one-parameter risk model
separately for the transmission model and for the parent-
phenotype model (we use the log-additive parameterization
though any one-parameter version could be used, such as a
dominant model). Second, form a composite statistic as a linear
combination of the test statistics from the separate fits. Let Xt
and Xp be the one degree-of-freedom likelihood ratio test (LRT)
chi-squared statistics where the subscripts, respectively, index
“transmission” and “parental-phenotype.” Let σt and σp be the
estimated standard errors of the estimated risk coefficients in the
two models and let St and Sp be the signs of the corresponding
coefficients. The composite statistic will take advantage of the fact
that under alternatives to the null the relative risk in the parental
phenotype model would likely be in the same direction as that
in the transmission-based model. The composite statistic exploits
that directional agreement to enhance power as follows:
ZC =
Sp
√
Xp/σ
2
p + St
√
Xt/σ
2
t√
1/σ 2p+1/σ
2
t
ZC is a linear combination of signed versions of the square
roots of one-degree-of-freedom chi-squared statistics. Under
the null, each of these has a standard normal distribution so
the linear combination also has a normal distribution, and the
coefficients are chosen so the linear combination has variance
1. Consequently, under the null, ZC follows a standard normal
distribution asymptotically and its square follows a chi-squared
distribution with 1 degree of freedom. We call the test based
on this statistic the parent-phenotype-informed composite test
(PPI-CT).
Diseases Affecting Both Males and Females
We next extend model (3) to accommodate diseases that can
affect both males and females. If, conditional on mating type,
the occurrence of disease in the mother is independent of the
occurrence of disease in the father, we write the log-binomial
model for parental disease status as:
ln
[
Pr
(
Disease in a particular parent|M, F,DC
)]
= α(M,F) + δ(M,F, parent is father)
+ β1I(M= 1, parent is mother) + β2I(M= 2, parent is mother)
+ θ1I(F= 1, parent is father) + θ2I(F= 2, parent is father) (5)
Exponentiating θ1 and θ2 yields estimates of the relative risks
for fathers who carry 1 or 2 copies compared to those who do
not carry the variant allele. The δ(M,F, parent is father) parameters
correspond to adjustments to the α(M,F) mating type parameters
that are needed to accommodate possible differences between
the baseline risks in fathers and those in mothers. This model
also allows formal testing of the equality of the relative risks in
mothers vs. fathers. When the relative risks do not appear to be
different, one can fit a single set of relative risk parameters for
mothers and fathers. Additionally, this model can be simplified
by using log-additive, recessive or dominant coding.
If there is concern about possible population stratification
such stratification could induce correlation between the parental
phenotypes. Shared risk factors, e.g., related to diet, could also
induce phenotype correlation in the two parents. This possible
correlation could be explored by including, for example, the
maternal phenotype as a predictor in the model for the paternal
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phenotype. Such correlationmay necessitate the use of dependent
data methods such as generalized estimating equations (GEE).
TDT and parenTDT
The TDT (Spielman et al., 1993) is a widely used transmission-
based test for di-allelic autosomal SNPs. The TDT has been
extended to incorporate parental phenotype data, parenTDT
(Purcell et al., 2007). The parenTDT, or the parental discordance
test, which is a simplified version of the method proposed by
Purcell et al. (2005), compares the number of alleles in affected vs.
unaffected parents within each family. Due to the within-family
matching, the parenTDT assumes only homogeneity within
families rather than among families and is resistant to bias from
population stratification. It discards as uninformative families
where both parents are affected.
One can combine information from TDT and parentTDT into
combTDT by summing counts of allele transmissions and allele
counts of phenotypically-discordant parents (Purcell et al., 2007).
Summing permits construction of a single chi-squared statistic
for testing.
Simulations and Noncentrality Parameter
Calculations
To evaluate power, we computed the noncentrality parameter
(NCP) of a chi-square test statistic by applying a well-known
method (Agresti, 1990), based on maximizing the likelihood
using the expected counts under a specified alternative scenario
as pseudo-data. The NCP for the likelihood ratio test is calculated
as the change in deviance (twice the maximized log likelihood)
between models that do vs. do not include the parameter(s)
of interest. We calculated the NCPs for the TDT methods
by similarly substituting expected counts for data in the test
statistics. Power was then calculated from the NCP based on
looking up the tail probabilities of the corresponding noncentral
chi-squared distribution. For comparisons to TDT methods
that provide one-degree-of-freedom (df) tests, we specified log-
additive risks and constrained the relative risks for the parent’s
and offspring’s phenotype to be the same so that our likelihood
ratio tests also had one df. We used simulations to confirm Type
I error rates and certain NCP-based power approximations and
to investigate estimation. For each scenario we simulated and
analyzed 5000 data sets. For the null scenarios, each simulated
study consisted of 300, 600, or 1200 case-parents triads. For the
alternative scenarios, each study consisted of 300 case-parent
triads.
NCPs permit easy extrapolation of power results to any other
sample size. For example, to calculate power for a different
sample size, say N, instead of the 300 that we used, one can
multiply the NCPs by N/300 to derive the new NCP and look up
the corresponding tail probabilities for a noncentral chi-squared
distribution.
To calculate expected counts, we first ignored mother’s
phenotype and calculated case-parent triad frequencies based
on the specified allele frequency, population structure, and
risk parameters [child inherited genetic effects (R1,R2) and
maternally-mediated genetic effects (S1, S2)]. For homogenous
populations, we assumed Hardy-Weinberg equilibrium (HWE);
for structured populations, we admixed two homogenous
populations with different allele frequencies and baseline risks.
We then calculated the frequencies of triads with an affected
mother by multiplying each triad frequency by the baseline risk
in mothers of affected offspring (that is, the risk in non-carrier
mothers, denoted maternal baseline risk, MBR), modified as
needed according to the mother’s genotype and the scenario’s
maternal relative risk parameters (Rm1,Rm2). We obtained the
frequency distribution of triads with unaffected mothers by
subtracting themother-affected triad frequencies from the overall
triad frequencies. In scenarios where both parents can be affected,
we first calculated the triad genotype frequencies stratified on the
mother’s phenotype. We then considered the father’s phenotype
in a similar way to further stratify the frequencies. The expected
counts were eventually obtained by multiplying the calculated
frequencies by 300, the total number of triads in the study.
We used simulations to explore the Type I error rates under
the null, with 5000 replicates of each simulated scenario. We
considered null scenarios in a homogenous population with or
without maternally-mediated genetic effects (S1 = S2 = 1; or
S1 = 1.4 and S2 = S
2
1 = 1.96). We also considered several
scenarios in which we assumed a stratified population with two
equal-sized subpopulations where the ratio of baseline disease
risks (risk in noncarriers) was either 1 or 3. The baseline disease
risks in mothers of affected offspring in the two subpopulations
were either the same (both equal to 0.2) or different (0.1 and
0.2 for the two subpopulations). The allele frequencies in the
two subpopulations were either the same (both equal to 0.3) or
different (0.1 and 0.3).
To evaluate power, we considered homogeneous populations
where R1 = Rm1 = 1.4 R2 = Rm2 = 1.96 and S1 = S2 = 1.
We first set the MBR as 0.2 and examined NCPs as a function
of allele frequencies. We also studied power as a function of
MBR under the same scenarios described above but with allele
frequency set at 0.3.
We studied missing-genotype scenarios that were similar to
the scenarios already mentioned except that 20% of the 300 triads
hadmissing genotypes for fathers and the EM algorithmwas used
to maximize the likelihoods. The MBR was 0.2 and the allele
frequencies ranged from 0.1 to 0.9. We also studied NCPs as
a function of fraction of fathers missing while setting the allele
frequency to 0.3.
Finally, we considered scenarios where either parent can be
affected. We examined NCPs as a function of allele frequency
while fixing the baseline risks in the mothers and fathers of
affected offspring as 0.2 and 0.1, respectively.
For complete triads the parent-phenotype test can serve as
a replication for triad-based findings, because it is statistically
independent from the transmission-based test. We explore this
potential use by comparing the relative risk estimates and z-
statistics from the triad-based and parent-based analyses using
simulations.
Results
The information from the two generations can be combined in
two ways: (1) the composite test based on ZC (PPI-CT); (2) the
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likelihood ratio test using the combined likelihood of formula
(1) with log-additive mode of inheritance (PPI-LRT). Under log-
additive risk scenarios these two tests perform very similarly
(data not shown). That similarity might be expected: the PPI-
CT is based on separate maximization of the transmission and
parental-phenotype models, each with its own risk parameter,
whereas the PPI-LRT maximizes a likelihood that is the product
of the same two likelihoods but with the relative risks for
mothers and for offspring constrained to be the same. Whether
fit separately or together under the constraint, if the models
are correctly-specified, the two tests should be similar for
large samples. In the following comparisons, we used PPI-CT
for scenarios with no missing data and PPI-LRT when some
genotypes are missing.
For Type I error rates, we evaluated the following tests: the log-
linear model with log-additive mode of inheritance for testing
transmission distortion (Offspring), the log-binomial model with
log-additive mode of inheritance for testing association with
parental phenotypes (Parent), the composite test based on ZC
(PPI-CT), TDT, parenTDT, and the combined TDT (combTDT).
In the absence of maternally-mediated genetic effects and when
the sample size was 300, Parent showed slightly inflated Type
I error rates of 0.06 and 0.066 for scenarios 3 and 4. This
inflation was due to the relatively small number of families that
were both genetically informative and had an affected mother,
which reduced the faithfulness of the asymptotic approximation.
When the sample size was increased to 600 or 1200, all
methods maintained nominal Type I error rates and Offspring
and Parent provided correct R1 and Rm1 estimates, respectively
(Tables 1B,C). As expected, the parenTDT and combTDT tests
showed inflated Type I error rates in the presence of maternally-
mediated genetic effects (row 5 inTables 1A–C). The Type I error
rate of the proposed methods depends on the risk parameters
Rm1 andRm2. TheRms can sometimes represent an amalgamation
of effects of the inherited genotype and maternally-mediated
genetic effects (R1 and R2, S1 and S2, respectively): in that event
one would expect the Rms to be between 1 and the maternally-
mediated relative risk. For example, in row 5 the apparent relative
risks for mother’s genotype on her own phenotype (Rm1 = 1.2,
Rm2 = 1.44) are between R1 = R2 = 1 and S1 = 1.4, S2 = 1.96,
because her genotype is confounded by the causative genotype of
her ownmother in that onematernally-mediated effects scenario.
The Parent, PPI-CT, parenTDT, and combTDT tests indeed show
inflated Type I error rates when there are maternally-mediated
effects.
To illustrate that the robustness of the parental-phenotype-
based test is due to the inclusion of the parental mating-type
parameters, we omitted them from model (3) and fit a single
intercept version to data from selected stratified scenarios. Type I
error rates increased from 0.057 to 0.211 and from 0.051 to 0.183
TABLE 1 | Type I error rates under the null, with disease affecting one sex.
Simulation scenarios Type I error rate R1 (95% CI)
MBR1, MBR2a Fr1, Fr2b BR1/BR2c Sd
1
Rm1 Offspring Parent PPI-CT TDT parenTDT combTDT Offspring Parent
(A) EACH DATA SET CONTAINS 300 FAMILIES.
0.2, 0.2 0.3, 0.3 1 1 1 0.046 0.054 0.047 0.046 0.049 0.048 1.00 (1.00, 1.00) 1.01 (1.00, 1.01)
0.2, 0.2 0.1, 0.3 3 1 1 0.054 0.056 0.051 0.053 0.048 0.048 1.00 (0.99, 1.00) 1.00 (0.99, 1.01)
0.1, 0.2 0.1, 0.3 1 1 1 0.045 0.060 0.050 0.045 0.052 0.048 1.00 (1.00, 1.01) 1.00 (0.99, 1.01)
0.1, 0.2 0.1, 0.3 3 1 1 0.046 0.066 0.049 0.046 0.055 0.047 1.00 (1.00, 1.01) 1.01 (0.99, 1.03)
0.2, 0.2 0.3, 0.3 1 1.4 1.2e 0.045 0.132 0.068 0.045 0.502 0.134 1.00 (1.00, 1.00) 1.21 (1.20, 1.22)
(B) EACH DATA SET CONTAINS 600 FAMILIES.
0.2, 0.2 0.3, 0.3 1 1 1 0.049 0.05 0.047 0.049 0.047 0.046 1.00 (1.00, 1.00) 1.00 (0.99, 1.00)
0.2, 0.2 0.1, 0.3 3 1 1 0.055 0.051 0.046 0.055 0.047 0.049 1.00 (1.00, 1.00) 1.00 (0.99, 1.00)
0.1, 0.2 0.1, 0.3 1 1 1 0.046 0.053 0.047 0.045 0.046 0.047 1.00 (1.00, 1.00) 1.00 (0.99, 1.01)
0.1, 0.2 0.1, 0.3 3 1 1 0.052 0.057 0.052 0.052 0.054 0.048 1.00 (0.99, 1.00) 1.00 (0.99, 1.01)
0.2, 0.2 0.3, 0.3 1 1.4 1.2e 0.052 0.196 0.089 0.052 0.805 0.227 1.00 (1.00, 1.00) 1.20 (1.19, 1.21)
(C) EACH DATA SET CONTAINS 1200 FAMILIES.
0.2, 0.2 0.3, 0.3 1 1 1 0.047 0.051 0.054 0.047 0.053 0.052 1.00 (1.00, 1.00) 1.00 (1.00, 1.00)
0.2, 0.2 0.1, 0.3 3 1 1 0.05 0.053 0.048 0.05 0.054 0.048 1.00 (1.00, 1.00) 1.00 (1.00, 1.00)
0.1, 0.2 0.1, 0.3 1 1 1 0.05 0.057 0.057 0.05 0.057 0.054 1.00 (1.00, 1.00) 1.00 (0.99, 1.00)
0.1, 0.2 0.1, 0.3 3 1 1 0.044 0.051 0.048 0.044 0.051 0.048 1.00 (1.00, 1.00) 1.00 (0.99, 1.01)
0.2, 0.2 0.3, 0.3 1 1.4 1.2e 0.05 0.323 0.141 0.05 0.98 0.411 1.00 (1.00, 1.00) 1.19 (1.19, 1.20)
aBaseline disease risks in mothers of affected offspring in subpopulation 1 and 2.
bAllele frequencies in subpopulation 1 and 2.
cRatio of baseline disease risk in subpopulation 1 vs. that in subpopulation 2.
dRelative risk for a child whose mother has one copy of the risk allele vs. those whose mother has none.
eA scenario without effects of the inherited genotype on offspring (R1 = R2 = 1) but with maternally-mediated genetic effects (S1 = 1.4, S2 = 1.96). The apparent relative risks for
mother’s genotype on her own phenotype are between the above two (Rm1 = 1.2, Rm2 = 1.44), because her genotype is confounded by the causative genotype of her own mother in
this scenario.
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in the two scenarios that we examined, documenting the need for
mating-type-based intercept parameters.
Under the alternative (non-null) scenarios, across different
allele frequencies our proposed Parent test always performed
better than parenTDT; so did our proposed PPI-CT vs. combTDT
(Figure 1). NCP calculations were also validated by simulations
and the Parent test showed unbiased relative risk estimates
(Supplemental Table 1). As the baseline risk in the mothers of
affected offspring increased from 0.05 to 0.45, the four tests all
showed increased power. Again Parent and PPI-CT performed
better than parenTDT and combTDT respectively, especially
when the baseline risk was high (Figure 2 and Supplemental
Figure 1).
When genotypes were missing from 20% of the fathers, PPI-
LRT was able to retrieve through use of the EM algorithm most
of the lost power due to missing data. The TDT-based approach,
however, suffered due to its need to discard families with missing
genotypes (Figure 3). The PPI-LRT, as expected, did lose power
as the missing rate increased (Figure 4). However, remarkably,
even when all fathers’ genotypes were missing the PPI-LRT still
had reasonable power, while combTDT had no power at all
(having no informative families left).
We observed similar patterns when the disease under
consideration could affect both males and females (Figure 5).
The power for the tests based on parental phenotypes and hence
for the combined tests was higher compared to scenarios where
only one sex was affected, due to the increased number of parent-
affected families.
FIGURE 1 | Noncentrality parameter and power as a function of allele
frequency. All designs used 300 complete triads in a homogenous population
under the risk scenario: R1 = Rm1 = 1.4, R2 = Rm2 = 1.96, and S1 = S2 = 1.
The baseline risk in mothers of affected offspring is 0.2. Vertical axes: left, the
chi-squared non-centrality parameter for a 1-df likelihood ratio test; right,
power at α = 0.05. Horizontal axis shows the allele frequency ranging from 0.1
to 0.9. Curves: dot, parenTDT; dash-dot, Parent; dash, combTDT; solid,
PPI-CT.
Another use of the parent-phenotype test when no
genotypes are missing is as a replication for findings from
the transmission-based test. We explored this role by examining
the agreements in relative risk estimates and the corresponding
Z statistics from the transmission-based and parent-phenotype-
based tests under scenarios for Figure 1 (Supplemental
Figure 2). Estimates from the two tests, although statistically
independent, were almost always in the same direction,
demonstrating that the test based on parental phenotype
can serve to independently confirm transmission-based
findings.
Application
The fibroblast growth factor receptor 2 (FGFR2), a cell surface
receptor with tyrosine-protein kinase activity, plays an essential
role in the regulation of cell proliferation, differentiation,
migration, and apoptosis. This gene has been consistently
identified as a risk locus for breast cancer, and 7 SNPs in FGFR2
have had a reported GWAS p-value less than 10−5 (Easton et al.,
2007; Hunter et al., 2007; Gaudet et al., 2010; Elgazzar et al.,
2012). We applied our method to genotypes of the 7 FGFR2
SNPs collected from 440 complete triads in the Two Sister Study
(Table 2). For all 7 SNPs, the parent-phenotype test produced
comparable relative risk estimates to the estimates based on the
transmission model, demonstrating replicability across the two
generations.With the added evidence from the parent-phenotype
test, the combined tests showed smaller p-values. Parent and
FIGURE 2 | Noncentrality parameter and power as a function of
baseline risk in mothers of affected offspring. All designs used 300
complete triads in a homogenous population under the risk scenario:
R1 = Rm1 = 1.4, R2 = Rm2 = 1.96, and S1 = S2 = 1. The risk allele
frequency is 0.3. Vertical axes: left, the chi-squared noncentrality
parameter for a 1-df likelihood ratio test; right, power at α = 0.05.
Horizontal axis shows the baseline risk in mothers of affected offspring
ranging from 0.05 to 0.45. Curves: dot, parenTDT; dash-dot, Parent;
dash, combTDT; solid, PPI-CT.
Frontiers in Genetics | www.frontiersin.org 6 June 2015 | Volume 6 | Article 221
Shi et al. Parent-phenotypes in case-parent studies
FIGURE 3 | Noncentrality parameter and power as a function of allele
frequency in the presence of missing genotypes. All designs used 300
triads from a homogeneous population with or without missing genotypes for
20% of the fathers. The risk scenario is: R1 = Rm1 = 1.4, R2 = Rm2 = 1.96,
and S1 = S2 = 1. The baseline risk in mothers of affected offspring is 0.2.
Vertical axes: left, the chi-squared noncentrality parameter for a 1-df likelihood
ratio test; right, power at α = 0.05. Horizontal axis shows the allele frequency
ranging from 0.1 to 0.9. Curves: dash, combTDT when genotypes are missing
from 20% of the fathers; dash-dot, PPI-LRT when genotypes are missing from
20% of the fathers; solid, PPI-LRT test when there are no missing genotypes
(this curve serves as a reference to show the impact of missing genotypes).
PPI-CT consistently gave smaller p-values than did parenTDT
and combTDT, respectively.
Discussion
Several methods have been proposed to extract information from
parental phenotypes. Whittemore and Tu (1998) proposed a
founder statistic that can take advantage of parent phenotype
information by comparing parent genotypes with those of the
reference population weighted by the phenotype value. This
founder statistic, however, requires correct specification of the
reference-genotype probabilities and is susceptible to bias under
population stratification. Purcell et al. (2005) proposed a method
that incorporates the parent phenotypes by inclusion of parental
genotype-phenotype correlation terms in the association tests.
This method can be used for dichotomous traits through a
liability-threshold-model approach. We use a simplified version
of this method (parenTDT) as a comparison in this paper.
Yu et al. (2013) proposed a method to incorporate parental
information into family-based association tests but instead
of using the information in direct testing of association,
their method uses parental information to infer the mode of
inheritance. A method that can make use of family-history data
in population-based case-control association studies has also
been proposed (Ghosh et al., 2014). Because parental genotypes
FIGURE 4 | Noncentrality parameter and power as a function of
missing genotype rates. All designs used 300 triads from a
homogeneous population with a range of missing genotype rates in the
fathers. The risk scenario is: R1 = Rm1 = 1.4, R2 = Rm2 = 1.96, and
S1 = S2 = 1. The baseline risk in mothers of affected offspring is 0.2.
Allele frequency was set at 0.3. Vertical axes: left, the chi-squared
noncentrality parameter for a 1-df likelihood ratio test; right, power at
α = 0.05. Horizontal axis shows the missing genotype rates in the fathers
ranging from 0 to 1. Curves: dash, combTDT; dash-dot, PPI-LRT; solid,
PPI-LRT test in the absence of missing genotypes which serves as a
reference to show the impact of missing genotypes.
FIGURE 5 | Noncentrality parameter and power as a function of allele
frequency under scenarios where both parents can be affected. All
designs used 300 complete triads in a homogenous population under the risk
scenario: R1 = Rm1 = 1.4, R2 = Rm2 = 1.96, and S1 = S2 = 1. The baseline
risk in mothers of affected offspring is 0.2 and 0.1 in fathers of affected
offspring. Vertical axes: left, the chi-squared noncentrality parameter for a 1-df
likelihood ratio test; right, power at α = 0.05. Horizontal axis shows the allele
frequency ranging from 0.1 to 0.9. Curves: dot, parenTDT; dash-dot, Parent;
dash, combTDT; solid, PPI-CT.
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TABLE 2 | Results from various tests applied to the breast cancer FGFR2 example.
rs Chr Position Test statistic p-value Relative risk estimate
Offspringa Parenta PPI-CTa TDT parenTDT combTDT Daughter Mother
rs3750817 10 123332577 0.337 0.279 0.181 0.337 1.000 0.379 0.91 (0.74, 1.11) 0.80 (0.53, 1.20)
rs2981579 10 123337335 0.010 0.123 0.003 0.010 0.467 0.008 1.29 (1.06, 1.57) 1.41 (0.90, 2.21)
rs1078806 10 123338975 0.017 0.172 0.006 0.013 0.529 0.011 1.27 (1.04, 1.56) 1.38 (0.86, 2.19)
rs2981578 10 123340311 0.020 0.116 0.006 0.020 0.564 0.018 0.79 (0.65, 0.97) 0.72 (0.48, 1.08)
rs2981575 10 123346116 0.008 0.265 0.004 0.008 0.714 0.010 1.30 (1.07, 1.59) 1.29 (0.83, 2.00)
rs1219648 10 123346190 0.019 0.197 0.008 0.019 0.617 0.018 1.27 (1.04, 1.54) 1.35 (0.85, 2.12)
rs2981582 10 123352317 0.027 0.142 0.009 0.027 0.541 0.023 1.25 (1.03, 1.52) 1.40 (0.89, 2.20)
aThese tests are likelihood ratio tests based on a log-additive mode of inheritance.
are not available for direct evaluation in a case-control study,
that method treats family-history as a “phenotype” and accounts
for the expected attenuation in strength of the association.
Evidence from the case-control comparison and family-history
comparison is then combined using a meta-analysis approach.
The method we have proposed here is robust to population
stratification, can provide relative risk estimates, and can handle
missing genotypes through use of the EM algorithm. With
complete triads, the parent-based test is independent of the
transmission-based test and can serve as an internal replicate
for findings based on transmission distortion. With incomplete
triads, however, requiring used of the EM to maximize the
likelihood, the independence of these two tests no longer
holds.
Some caveats need to be mentioned. The log-binomial model
will resist convergence (Williamson et al., 2013) when excursions
during iteration take fitted probabilities below 0 or above 1.0. In
analyzing our simulated data we avoided this issue by assigning
reasonable starting values.
Another issue is that without grandparent genotype data
the parent-based model cannot distinguish a maternally-
mediated (here grandmother-mediated) effect from an inherited
gene effect. Consequently, the estimated relative risks can
be biased if a maternally-mediated effect is involved. These
problems also apply to other approaches, such as a case-control
association study, but they are rarely acknowledged. Finally,
while incorporating information related to parental phenotypes
should always add power, that power gain will be modest if the
disease is rare in parents of affected offspring. Breast cancer
was a likely candidate, because its lifetime risk is so high
(approximately 12% per Howlader et al., 2012).
Some assumptions beyond the usual Mendelian inheritance
assumption are needed for strict validity of the estimation of
relative risks. Because DC is not incorporated as a predictor in
model (3), epistasis can potentially produce bias (away from the
null) in estimation based on that parental phenotype model if
genetic background acts synergistically with the variant under
analysis. However, there was little evidence of that phenomenon
in our breast cancer example.
Family-based studies often collect parent phenotype data
and consequently improved methods for using that data to
enhance genetic risk assessment will be widely applicable. Our
proposed strategy for combining parent-phenotype information
with genotype data from case-parents designs resists bias due to
population structure, delivers improved power, provides relative
risk estimates and can handle missing genotypes, thereby offering
advantages over existing approaches.
Acknowledgments
This research was supported by the Intramural Research Program
of the NIH, National Institute of Environmental Health Sciences,
under project numbers Z01 ES040007 and Z01 ES045002 and
by Susan G. Komen for the Cure (FAS 0703856). We thank Drs
Dmitri Zaykin and Katie O’Brien for their careful review and
valuable comments.
Supplementary material
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fgene.
2015.00221
References
Agresti, A. (1990). Categorical Data Analysis. New York, NY: John Wiley & Sons.
Dempster, A. P., Laird, N. M., and Rubin, D. B. (1977). Maximum Likelihood from
Incomplete Data via the EM Algorithm. J. R. Stat. Soc. B Methodol. 39, 1–38.
Easton, D. F., Pooley, K. A., Dunning, A. M., Pharoah, P. D., Thompson, D.,
Ballinger, D. G., et al. (2007). Genome-wide association study identifies
novel breast cancer susceptibility loci. Nature 447, 1087–1093. doi:
10.1038/nature05887
Elgazzar, S., Zembutsu, H., Takahashi, A., Kubo,M., Aki, F., Hirata, K., et al. (2012).
A genome-wide association study identifies a genetic variant in the SIAH2 locus
associated with hormonal receptor-positive breast cancer in Japanese. J. Hum.
Genet. 57, 766–771. doi: 10.1038/jhg.2012.108
Fulker, D. W., Cherny, S. S., Sham, P. C., and Hewitt, J. K. (1999). Combined
linkage and association sib-pair analysis for quantitative traits. Am. J. Hum.
Genet. 64, 259–267. doi: 10.1086/302193
Gaudet, M. M., Kirchhoff, T., Green, T., Vijai, J., Korn, J. M., Guiducci, C.,
et al. (2010). Common genetic variants and modification of penetrance
Frontiers in Genetics | www.frontiersin.org 8 June 2015 | Volume 6 | Article 221
Shi et al. Parent-phenotypes in case-parent studies
of BRCA2-associated breast cancer. PLoS Genet. 6:e1001183. doi:
10.1371/journal.pgen.1001183
Ghosh, A., Hartge, P., Kraft, P., Joshi, A. D., Ziegler, R. G., Barrdahl, M., et al.
(2014). Leveraging family history in population-based case-control association
studies. Genet. Epidemiol. 38, 114–122. doi: 10.1002/gepi.21785
Howlader, N., Noone, A., Krapcho, M., Neyman, N., Aminou, R., Waldron,
W., et al. (2012). SEER Cancer Statistics Review, 1975-2009 (Vintage 2009
Populations). Bethesda, MD: National Cancer Institute.
Hunter, D. J., Kraft, P., Jacobs, K. B., Cox, D. G., Yeager, M., Hankinson, S. E., et al.
(2007). A genome-wide association study identifies alleles in FGFR2 associated
with risk of sporadic postmenopausal breast cancer. Nat. Genet. 39, 870–874.
doi: 10.1038/ng2075
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A., Bender, D., et al.
(2007). PLINK: a tool set for whole-genome association and population-based
linkage analyses. Am. J. Hum. Genet. 81, 559–575. doi: 10.1086/519795
Purcell, S., Sham, P., and Daly, M. J. (2005). Parental phenotypes in family-based
association analysis. Am. J. Hum. Genet. 76, 249–259. doi: 10.1086/427886
Spielman, R. S., McGinnis, R. E., and Ewens, W. J. (1993). Transmission test for
linkage disequilibrium: the insulin gene region and insulin-dependent diabetes
mellitus (IDDM). Am. J. Hum. Genet. 52, 506–516.
Weinberg, C. R., Wilcox, A. J., and Lie, R. T. (1998). A log-linear approach to case-
parent-triad data: assessing effects of disease genes that act either directly or
through maternal effects and that may be subject to parental imprinting. Am. J.
Hum. Genet. 62, 969–978. doi: 10.1086/301802
Whittemore, A. S., and Tu, I. P. (1998). Simple, robust linkage tests
for affected sibs. Am. J. Hum. Genet. 62, 1228–1242. doi: 10.1086/
301820
Wilcox, A. J., Weinberg, C. R., and Lie, R. T. (1998). Distinguishing the
effects of maternal and offspring genes through studies of “case-parent
triads.” Am. J. Epidemiol. 148, 893–901. doi: 10.1093/oxfordjournals.aje.a0
09715
Williamson, T., Eliasziw, M., and Fick, G. H. (2013). Log-binomial models:
exploring failed convergence. Emerg. Themes Epidemiol. 10:14. doi:
10.1186/1742-7622-10-14
Yu, Z., Gillen, D., Li, C. F., and Demetriou, M. (2013). Incorporating parental
information into family-based association tests. Biostatistics 14, 556–572. doi:
10.1093/biostatistics/kxs048
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2015 Shi, Umbach and Weinberg. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Genetics | www.frontiersin.org 9 June 2015 | Volume 6 | Article 221
